BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20410637)

  • 21. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
    Kasibhatla B; Wos J; Peters KG
    Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QSAR studies of PTP1B inhibitors: recent advances and perspectives.
    Luan F; Xu X; Liu HT; Cordeiro MN; Zhang XY
    Curr Med Chem; 2012; 19(25):4208-17. PubMed ID: 22834811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance].
    Boduła A; Wdowczyk M; Adamiec R
    Postepy Hig Med Dosw (Online); 2005 May; 59():203-7. PubMed ID: 15928604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
    Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.
    Ma Y; Sun SX; Cheng XC; Wang SQ; Dong WL; Wang RL; Xu WR
    Chem Biol Drug Des; 2013 Nov; 82(5):595-602. PubMed ID: 23848232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
    Cerón-Romero L; Paoli P; Camici G; Flores-Morales V; Rios MY; Ramírez-Espinosa JJ; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2018-22. PubMed ID: 26961283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
    J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein Tyrosine Phosphatase 1B Inhibition and Glucose Uptake Potentials of Mulberrofuran G, Albanol B, and Kuwanon G from Root Bark of
    Paudel P; Yu T; Seong SH; Kuk EB; Jung HA; Choi JS
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
    Morishita K; Shoji Y; Tanaka S; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2017; 65(12):1144-1160. PubMed ID: 29199219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
    Liu P; Du Y; Song L; Shen J; Li Q
    Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursolic acid derivatives as potential antidiabetic agents: In vitro, in vivo, and in silico studies.
    Guzmán-Ávila R; Flores-Morales V; Paoli P; Camici G; Ramírez-Espinosa JJ; Cerón-Romero L; Navarrete-Vázquez G; Hidalgo-Figueroa S; Yolanda Rios M; Villalobos-Molina R; Estrada-Soto S
    Drug Dev Res; 2018 Mar; 79(2):70-80. PubMed ID: 29380400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
    Chen YT; Tang CL; Ma WP; Gao LX; Wei Y; Zhang W; Li JY; Li J; Nan FJ
    Eur J Med Chem; 2013 Nov; 69():399-412. PubMed ID: 24090912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.